| Outgoing Relation(s) |
| biochemical role (CHEBI:52206) is a biological role (CHEBI:24432) |
| Incoming Relation(s) |
| carboxymethyl-pachyman (CHEBI:176806) has role biochemical role (CHEBI:52206) |
| cis-Golgi ArfGEF GBF inhibitor (CHEBI:139084) is a biochemical role (CHEBI:52206) |
| actin polymerisation inducer (CHEBI:176495) is a biochemical role (CHEBI:52206) |
| antimetabolite (CHEBI:35221) is a biochemical role (CHEBI:52206) |
| antisense oligonucleotide (CHEBI:76720) is a biochemical role (CHEBI:52206) |
| apoptosis inducer (CHEBI:68495) is a biochemical role (CHEBI:52206) |
| apoptosis inhibitor (CHEBI:68494) is a biochemical role (CHEBI:52206) |
| ATP/ADP translocase inhibitor (CHEBI:77750) is a biochemical role (CHEBI:52206) |
| ATPase motor cytoplasmic dynein inhibitor (CHEBI:138090) is a biochemical role (CHEBI:52206) |
| autophagy inducer (CHEBI:138880) is a biochemical role (CHEBI:52206) |
| autophagy inhibitor (CHEBI:88230) is a biochemical role (CHEBI:52206) |
| axin stabilizer (CHEBI:62914) is a biochemical role (CHEBI:52206) |
| B-cell lymphoma 2 inhibitor (CHEBI:133022) is a biochemical role (CHEBI:52206) |
| BET bromodomain inhibitor (CHEBI:231729) is a biochemical role (CHEBI:52206) |
| breast cancer resistance protein inhibitor (CHEBI:72771) is a biochemical role (CHEBI:52206) |
| cell dedifferentiation agent (CHEBI:70724) is a biochemical role (CHEBI:52206) |
| centromere protein E inhibitor (CHEBI:234476) is a biochemical role (CHEBI:52206) |
| CETP inhibitor (CHEBI:49205) is a biochemical role (CHEBI:52206) |
| cofactor (CHEBI:23357) is a biochemical role (CHEBI:52206) |
| complement component 5 inhibitor (CHEBI:229668) is a biochemical role (CHEBI:52206) |
| complement factor B inhibitor (CHEBI:229655) is a biochemical role (CHEBI:52206) |
| CPSF3 inhibitor (CHEBI:167633) is a biochemical role (CHEBI:52206) |
| effector (CHEBI:35224) is a biochemical role (CHEBI:52206) |
| elicitor (CHEBI:192504) is a biochemical role (CHEBI:52206) |
| enzyme activator (CHEBI:195252) is a biochemical role (CHEBI:52206) |
| enzyme inhibitor (CHEBI:23924) is a biochemical role (CHEBI:52206) |
| enzyme reactivator (CHEBI:50242) is a biochemical role (CHEBI:52206) |
| eukaryotic initiation factor 4F inhibitor (CHEBI:137079) is a biochemical role (CHEBI:52206) |
| eukaryotic translation elongation factor 1α 1 inhibitor (CHEBI:90767) is a biochemical role (CHEBI:52206) |
| exportin 1 inhibitor (CHEBI:229763) is a biochemical role (CHEBI:52206) |
| fatty acid oxidation inhibitor (CHEBI:133190) is a biochemical role (CHEBI:52206) |
| ferroptosis inducer (CHEBI:173085) is a biochemical role (CHEBI:52206) |
| ferroptosis inhibitor (CHEBI:173084) is a biochemical role (CHEBI:52206) |
| ferroptosis suppressor protein 1 inhibitor (CHEBI:176508) is a biochemical role (CHEBI:52206) |
| hepatitis C virus nonstructural protein 5A inhibitor (CHEBI:85185) is a biochemical role (CHEBI:52206) |
| histamine releasing agent (CHEBI:75298) is a biochemical role (CHEBI:52206) |
| lipopolysaccharide biosynthesis inhibitor (CHEBI:134108) is a biochemical role (CHEBI:52206) |
| macrophage migration inhibitory factor inhibitor (CHEBI:91214) is a biochemical role (CHEBI:52206) |
| metabolite (CHEBI:25212) is a biochemical role (CHEBI:52206) |
| MTP inhibitor (CHEBI:72298) is a biochemical role (CHEBI:52206) |
| necroptosis inhibitor (CHEBI:167704) is a biochemical role (CHEBI:52206) |
| NLRP3 inhibitor (CHEBI:231916) is a biochemical role (CHEBI:52206) |
| nonnucleoside hepatitis C virus polymerase inhibitor (CHEBI:85180) is a biochemical role (CHEBI:52206) |
| nonstructural protein 5A inhibitor (CHEBI:83799) is a biochemical role (CHEBI:52206) |
| PCNA inhibitor (CHEBI:195530) is a biochemical role (CHEBI:52206) |
| peptidomimetic (CHEBI:63175) is a biochemical role (CHEBI:52206) |
| phospholipid biosynthesis inhibitor (CHEBI:83741) is a biochemical role (CHEBI:52206) |
| photobiochemical role (CHEBI:52216) is a biochemical role (CHEBI:52206) |
| RhoA inhibitor (CHEBI:138380) is a biochemical role (CHEBI:52206) |
| RhoC inhibitor (CHEBI:138381) is a biochemical role (CHEBI:52206) |
| S100 calcium-binding protein B inhibitor (CHEBI:136651) is a biochemical role (CHEBI:52206) |
| secretagogue (CHEBI:90414) is a biochemical role (CHEBI:52206) |
| signal transducer and activator of transcription 5 protein inhibitor (CHEBI:87786) is a biochemical role (CHEBI:52206) |
| sodium-glucose transport protein subtype 1 inhibitor (CHEBI:229227) is a biochemical role (CHEBI:52206) |
| sodium-glucose transport protein subtype 2 inhibitor (CHEBI:73273) is a biochemical role (CHEBI:52206) |
| STAT3 inhibitor (CHEBI:87183) is a biochemical role (CHEBI:52206) |
| steatosis inducing agent (CHEBI:83609) is a biochemical role (CHEBI:52206) |
| steroid receptor coactivator stimulator (CHEBI:90991) is a biochemical role (CHEBI:52206) |
| sterol biosynthesis inhibitor (CHEBI:83317) is a biochemical role (CHEBI:52206) |
| teichoic acid biosynthesis inhibitor (CHEBI:131611) is a biochemical role (CHEBI:52206) |
| thioredoxin inhibitor (CHEBI:173108) is a biochemical role (CHEBI:52206) |
| vesicular glutamate transport inhibitor (CHEBI:72483) is a biochemical role (CHEBI:52206) |
| vitamin (role) (CHEBI:33229) is a biochemical role (CHEBI:52206) |
| volatile oil component (CHEBI:27311) is a biochemical role (CHEBI:52206) |
| Wiskott-Aldrich syndrome protein inhibitor (CHEBI:78009) is a biochemical role (CHEBI:52206) |
